3m Innovative Properties Company

Coley Pharmaceutical Group, Inc.

Ryan B Prince

David S Hays

Philip D Heppner

Tushar A Kshirsagar

Clinton L Jones

G Marco Bommarito

Alexander J Kugel

Jason D Bonk

Cori S Apel

John F Gerster

Mario Alberto Perez

William H Moser

Shri Niwas

Maureen Ann Kavanagh

Sarah A Strong

Matthew R Radmer

Michael E Danielson

Joshua R Wurst

Joan T Moseman

Bryon A Merrill

Michael J Rice

Dana R Reed

Stuart E Fores

Karl E Benson

Ross E Behling

Christopher A Haak

Chad A Haraldson

John L Battiste

Robert J Webb

Karl J Manske

Anish Kurian

Steven Richard Austin

Adam R Wohl

Howard S Creel

Angela K Dillow

Craig A Kapfer

Scott M Fabozzi

Sehban Ozair

Randall P Brown

Cori S Griesgraber

Carson MacCallum

Shawn R Sweeney

Protected photocrosslinkers and their use in two-stage photocuring of (meth)acrylate monomers is described.

Acrylic adhesive composition from protected photocrosslinking agents

Two-part coating compositions are described comprising an aliphatic cyclic secondary amine and methods of coating surfaces of a (e.g. drinking water) pipeline.

Composition comprising cyclic secondary amine and methods of coating drinking water pipelines

A pavement marking composition comprises an isocyanate-containing component and an amine-containing component. At least one of the components comprises plasticizer and at least one of the components comprises filler. The composition comprises about 5 wt. % or more plasticizer and is substantially free of polyaspartic ester amines.

Pavement marking compositions

An in-situ applicator for applying a composition in a pipe comprises a flow diverter configured to receive a composition and eject the composition from at least one outlet. The applicator also comprises a hollow conical body having a narrow end, a broad end, and an interior surface configured to receive the composition ejected from the flow diverter. The conical body also has a plurality of holes forming a band that wraps circumferentially around the conical body which defines a flow region on the interior surface between the band and the narrow end. The band includes first holes adjacent to the flow region where each of the first holes has a first average diameter and second holes disposed between the first holes and the broad end, each of the second holes having an average diameter greater than the first diameter.

Apparatus for in-situ pipe coating and related methods

A curable composition includes: a) at least one aliphatic polyisocyanate; b) at least one aliphatic polyamine; and c) from 8 to 17 percent by weight of at least one liquid compound, based on the total weight of components a), b) and c) combined. Each liquid compound is independently represented by the formula (I): wherein Z represents an n valent organic group, and n represents an integer &#x2267;1. Methods of coating the curable coating on a substrate and composite articles are also disclosed. 

Curable polyurea forming composition, method of making, and composite article

Thiazoloquinolines and thiazolonaphthyridines with an alkoxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines

An article for securing a window film to a window frame includes an elongate body having a first end and a second end, a first portion having a first attachment surface extending from the first end to the second end, a connecting portion extending outwardly from the first portion opposite the first attachment surface, and a second portion joined with the end of the connecting portion opposite the first portion. Methods of anchoring an applied window film to a window frame using the article are also disclosed.

Window film attachment article

Pyrazolopyridin-4-amines, pyrazoloquinolin-4-amines, pyrazolonaphthyridin-4-amines, 6,7,8,9-tetrahydropyrazoloquinolin-4-amines, and prodrugs thereof, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

Pyrazolopyridines and analogs thereof

Diacetylenic materials for the colorimetric detection of an analyte or exposure to certain environmental factors are disclosed as well as the polymerization reaction products of these diacetylenic compounds.

Diacetylenic materials for sensing applications

Thiazoloquinoline and thiazolonaphthyridine compounds having an aryloxy or arylalkyleneoxy substituent at the 6-, 7-, 8-, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines

Pyrazolo[3,4-c] ring compounds of Formula (I), e.g., pyrazolo[3,4-c]pyridines, pyrazolo[3,4-c]quinolines, 6,7,8,9-tetrahydro pyrazolo[3,4-c]quinolines, and pyrazolo[3,4-c]naphthyridines, substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases

Pyrazolopyridin-4-amines, pyrazoloquinolin-4-amines, pyrazolonaphthyridin-4-amines, and 6,7,8,9-tetrahydropyrazoloquinolin-4-amines, pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

Growing community of inventors

Saint Paul, MN, United States of America

Ryan B Prince